Kristin Toftaker Killingberg
+4747386257
Kunnskapssenteret, Øya
About
Publications
2023
-
Killingberg, Kristin Toftaker;
Grønberg, Bjørn Henning;
Jordhøy, Marit Slaaen;
Kirkevold, Øyvind;
Halvorsen, Tarje Onsøien.
(2023)
Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC.
Journal of Thoracic Oncology
Academic article
2022
-
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien;
Fløtten, Øystein;
Brustugun, Odd Terje;
Langer, Seppo W.;
Nyman, Jan.
(2022)
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Lung Cancer
Academic article
-
Levin, Nina;
Danielsen, Signe;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Redalen, Kathrine Røe;
Grønberg, Bjørn Henning.
(2022)
Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer.
Radiotherapy and Oncology
Abstract
-
Stokke, Kristin;
Halvorsen, Tarje Onsøien;
Grønberg, Bjørn Henning;
Saltvedt, Ingvild;
Jordhøy, Marit Slaaen;
Kirkevold, Øyvind.
(2022)
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC.
Healthcare
Academic article
-
Stokke, Kristin;
Sandvei, Marie Søfteland;
Grønberg, Bjørn Henning;
Jordhøy, Marit Slaaen;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2022)
Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer.
Clinical Medicine Insights: Oncology
Academic article
2021
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Fløtten, Øystein;
Brustugun, Odd;
HORNSLIEN, KJERSTI;
Madebo, Tesfaye.
(2021)
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
The Lancet Oncology
Academic article
2020
-
Halvorsen, Tarje Onsøien;
Stokke, Kristin;
Killingberg, Kristin Toftaker;
Raj, Sunil Xavier;
Sørhaug, Sveinung;
Brustugun, Odd Terje.
(2020)
Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC.
Acta Oncologica
Academic article
Journal publications
-
Killingberg, Kristin Toftaker;
Grønberg, Bjørn Henning;
Jordhøy, Marit Slaaen;
Kirkevold, Øyvind;
Halvorsen, Tarje Onsøien.
(2023)
Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC.
Journal of Thoracic Oncology
Academic article
-
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien;
Fløtten, Øystein;
Brustugun, Odd Terje;
Langer, Seppo W.;
Nyman, Jan.
(2022)
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Lung Cancer
Academic article
-
Levin, Nina;
Danielsen, Signe;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Redalen, Kathrine Røe;
Grønberg, Bjørn Henning.
(2022)
Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer.
Radiotherapy and Oncology
Abstract
-
Stokke, Kristin;
Halvorsen, Tarje Onsøien;
Grønberg, Bjørn Henning;
Saltvedt, Ingvild;
Jordhøy, Marit Slaaen;
Kirkevold, Øyvind.
(2022)
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC.
Healthcare
Academic article
-
Stokke, Kristin;
Sandvei, Marie Søfteland;
Grønberg, Bjørn Henning;
Jordhøy, Marit Slaaen;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2022)
Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer.
Clinical Medicine Insights: Oncology
Academic article
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Fløtten, Øystein;
Brustugun, Odd;
HORNSLIEN, KJERSTI;
Madebo, Tesfaye.
(2021)
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
The Lancet Oncology
Academic article
-
Halvorsen, Tarje Onsøien;
Stokke, Kristin;
Killingberg, Kristin Toftaker;
Raj, Sunil Xavier;
Sørhaug, Sveinung;
Brustugun, Odd Terje.
(2020)
Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC.
Acta Oncologica
Academic article
Knowledge Transfer
2023
-
LectureLevin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2023) Dose-response of acute esophagitis for limited stage small cell lung cancer - Data from a randomized phase II trial. Acta Oncologica BiGART , Aarhus, Danmark 2023-06-20 - 2023-06-21
2022
-
LectureLevin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2022) Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer. European Society for Radiotherapy and Oncology (ESTRO) ESTRO 2022 , København 2022-05-06 - 2022-05-10
2019
-
PosterStokke, Kristin; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Sørhaug, Sveinung; Madebo, Tesfaye; Raj, Sunil Xavier. (2019) Randomized phase III trial comparing maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Verdenskonferansen for lungekreft, WCLC , Barcelona 2019-09-07 - 2019-09-10